0001161697-24-000253.txt : 20240605 0001161697-24-000253.hdr.sgml : 20240605 20240605170021 ACCESSION NUMBER: 0001161697-24-000253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harper Molly CENTRAL INDEX KEY: 0001871470 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 241022810 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 06-03-2024 X0508 4 2024-06-03 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001871470 Harper Molly 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 0 0 0 0 Common Stock, par value $0.001 per share 2024-06-03 4 S 0 5333 16.304 D 0 D Shares were sold for personal reasons and not as a result of any disagreement with the Company. Ms. Harper remains a director of the Company. Represents a weighted average price for the shares sold. Shares were sold in a range between $16.26 and $16.34 per share. /s/ Molly Harper 2024-06-05